Recently, TREM-2 and TREM-1 emerged as key players in those inflammatory alterations affecting both the gut and the microbiota-gut-brain axis, which might be relevant in the pathogenesis and comorbidity of IBD and neurodegenerative disorders. This evidence concerns the gene TREM2 and inflammatory bowel disease.